| 期 |
栏目 |
标题 |
文件 |
| 卷 81, 编号 9 (2009) |
Editorial |
Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment |
|
| 卷 82, 编号 8 (2010) |
Editorial |
Risk factors for venous thromboembolic events and their association with D-dimer level |
|
| 卷 83, 编号 3 (2011) |
Editorial |
Genetic polymorphisms coding hemostasis protein synthesis and venous thromboembolic complications in Moscow population |
|
| 卷 83, 编号 6 (2011) |
Editorial |
Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage |
|
| 卷 83, 编号 8 (2011) |
Editorial |
Prolongation of enoxaparin therapy to one month promotes recanalization of occlusively thrombosed deep veins |
|
| 卷 83, 编号 12 (2011) |
Editorial |
Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications |
|
| 卷 90, 编号 9 (2018) |
Editorial |
Proton pump inhibitors receiving and prognosis of patients after scheduled percutaneous coronary interventions |
(Rus)
|
| 卷 91, 编号 9 (2019) |
Editorial |
Thrombotic and hemorrhagic complications in atrial fibrillation patients, undergoing elective percutaneous coronary intervention |
(Rus)
|
| 卷 92, 编号 9 (2020) |
Original articles |
Resumption of anticoagulant therapy after major bleeding and recurrence of hemorrhagic complications in patients with atrial fibrillation with a high risk of stroke and thromboembolism (based on the results of 20 years of observation) |
(Rus)
|
| 卷 92, 编号 9 (2020) |
Original articles |
Upper gastrointestinal bleeding in patients with stable coronary artery disease (registry of antithrombotic therapy “REGATТA” results) |
(Rus)
|
| 卷 91, 编号 6 (2019) |
Articles |
Antithrombotic therapy of coronary heart disease: time - tested essential principles |
(Rus)
|
| 卷 95, 编号 9 (2023) |
Original articles |
Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease |
(Rus)
|
| 卷 93, 编号 9 (2021) |
Original articles |
Severe gastrointestinal bleeding in patients with atrial fibrillation receiving oral anticoagulants (based on REGistry of long-term AnTithrombotic TherApy – REGATTA) |
(Rus)
|
| 卷 93, 编号 12 (2021) |
Original articles |
Gastric mucosa condition in patients with coronary artery disease and high risk of gastrointestinal bleeding (register REGATTA-1) |
(Rus)
|
| 卷 94, 编号 9 (2022) |
Clinical notes |
Patent foramen ovale as the cause of recurrent embolic strokes. Case report |
(Rus)
|
| 卷 94, 编号 9 (2022) |
Consensuns |
"Guiding lights" for the diagnosis of chronic thromboembolic pulmonary hypertension in the flow of patients with pulmonary embolism |
(Rus)
|
| 卷 94, 编号 12 (2022) |
Original articles |
Resumption of anticoagulant therapy after major bleeding and the risk of negative events in patients with atrial fibrillation (based on REGistry of Long-term AnTithrombotic TherApy-2 – REGATA) |
(Rus)
|
